First-in-human Study of MRT-6160 in Healthy Subjects

NCT06597799 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

108

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: MRT-6160
DRUG: Placebo

Sponsor

Monte Rosa Therapeutics, Inc